Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline pharmacokinetics in nontuberculous mycobacterial disease
NL-OMON54666Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of minocycline and rifampicin in nontuberculous mycobacteria infection, sponsored by Radboud University Medical Center. Primary endpoints: Minocycline AUC0-24h, Minocycline Ctrough and 1 more. Started Jun 2023; status: recruiting.
02
Drugs
minocyclinerifampicin
03
Conditions
nontuberculous mycobacteria infection
Beyond the preview
Go deeper on NL-OMON54666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54666.